Search terms
Results 11 - 20 of 63 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 7

See page 1772 for the editorial comment on this article (doi:10.1093/eurheartj/eht136) Introduction Chronic kidney disease (CKD) is a major public health problem.1 Cardiovascular disease (CVD) ...

European Heart Journal, Hou, Wanyin, Lv, Jicheng, Perkovic, Vlado, Yang, Lihong, Zhao, Na, Jardine, Meg J., Cass, Alan, Zhang, Hong, Wang, Haiyan

Date : 21/06/2013

Abstract Aims To compare the efficacy [low-density lipoprotein cholesterol (LDL-C) lowering] and safety of alirocumab, a fully human monoclonal antibody to proprotein convertase subtilisin/kexin 9, ...

European Heart Journal, Cannon, Christopher P., Cariou, Bertrand, Blom, Dirk, McKenney, James M., Lorenzato, Christelle, Pordy, Robert, Chaudhari, Umesh, Colhoun, Helen M.

Date : 14/05/2015 Item size : 271307 bytes

Abstract The value of cholesterol lowering in preventing cardiovascular disease has now been established in patients with chronic kidney disease (CKD), who are intrinsically at high cardiovascular ...

European Heart Journal, Wong, Muh Geot, Wanner, Christoph, Knight, John, Perkovic, Vlado

Date : 14/11/2015

Use of high-sensitivity C-reactive protein, which, amongst other biomarkers, is associated with cardiovascular risk, has been prominent in such analyses.3 In this issue of the journal,4 and in ...

European Heart Journal, Chapman, M. John, Giral, Philippe, Barter, Philip J.

Date : 07/05/2013 Item size : 133046 bytes

[...]a substantial number of statin-treated patients who are in the recommended range of low-density lipoprotein cholesterol (LDL-C) levels still develop cardiovascular events.1,2 One of the markers ...

European Heart Journal, Sondermeijer, Brigitte M., Boekholdt, S. Matthijs, Rana, Jamal S., Kastelein, John J.P., Wareham, Nicholas J., Khaw, Kay-Tee

Date : 07/05/2013 Item size : 200584 bytes

The European guidelines on cardiovascular disease prevention and management of stable coronary artery disease recommend a spectrum of measures to limit the risk of a first or recurrent coronary ...

European Heart Journal, Simoons, Maarten L., Deckers, Jaap W.

Date : 07/02/2016 Item size : 191475 bytes

Rather, they do so to better target therapy and improve the lives of their patients. [...]when considering the use of any biomarker for cardiovascular risk prediction in primary prevention, ...

European Heart Journal, Ridker, Paul M, Kastelein, John J.P., Genest, Jacques, Koenig, Wolfgang

Date : 01/05/2013 Item size : 180317 bytes

[...]atorvastatin has raked in around US$130 billion for Pfizer during its 14 years on the market, making it currently the world's bestselling drug.3 Recent studies show that statins possess powerful ...

European Heart Journal, Nordmann, Alain J., Briel, Matthias

Date : 01/07/2012

[...]the 2016 update of the European guidelines on cardiovascular disease prevention in clinical practice,3 issued jointly by the European Society of Cardiology (ESC) and nine other societies, ...

European Heart Journal, Mortensen, Martin Bødtker, Falk, Erling

Date : 10/03/2017 Item size : 182315 bytes

Abstract Aims Our aims were to evaluate the distribution of troponin I concentrations in population cohorts across Europe, to characterize the association with cardiovascular outcomes, to determine ...

European Heart Journal, Blankenberg, Stefan, Salomaa, Veikko, Makarova, Nataliya, Ojeda, Francisco, Wild, Philipp, Lackner, Karl J., Jørgensen, Torben, Thorand, Barbara, Peters, Annette, Nauck, ...

Date : 07/08/2016 Item size : 392256 bytes